Healio
SearchLoading
Healio
SearchLoading

American Headache Society Annual Meeting
ByKen Downey Jr.
ByYi-Chieh Chen, PharmD

Read more

June 17, 2022
5 min watch
Save

VIDEO: Pilot study yields wide range of effective, tolerable verapamil doses for migraine

ByKen Downey Jr.
ByYi-Chieh Chen, PharmD

DENVER — Verapamil was shown to be tolerable for migraine prevention at a maximum dose of 20 mg to 480 mg per day, Yi-Chieh Chen, PharmD, said at the American Headache Society’s annual scientific meeting.

“We found a wide range of minimally effective and tolerable verapamil doses in a cohort with various pharmacogenomic phenotypes,” Chen, of the Mayo Clinic in Rochester, Minnesota, said.

Sources/Disclosures

Collapse
Source:

Chen Y, et al. Pharmacogenomics — One step closer to precision medicine in headache? A pilot, exploratory study of the effect of pharmacogenomic phenotypes on the adequate dosing of Verapamil for migraine prevention. Presented at: American Headache Society annual scientific meeting; June 9-12, 2022; Denver.

Disclosures: Chen reports no relevant financial disclosures.

Read more from American Headache Society Annual Meeting

View all

Read more about

migraine
verapamil
 

Related Content